HELLP syndrome and postpartum corticosteroids
| Autor: | T Aydın, Füsun Varol, Fatih Gücer |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Blood Platelets
HELLP Syndrome medicine.medical_specialty HELLP syndrome medicine.drug_class Dexamethasone Preeclampsia Obstetrics and gynaecology Pregnancy medicine Humans Aspartate Aminotransferases Infusions Intravenous Glucocorticoids reproductive and urinary physiology Retrospective Studies L-Lactate Dehydrogenase Obstetrics business.industry Postpartum Period Obstetrics and Gynecology Alanine Transaminase Retrospective cohort study General Medicine medicine.disease Surgery Corticosteroid Female business Postpartum period medicine.drug |
| Zdroj: | International Journal of Gynecology & Obstetrics. 73:157-159 |
| ISSN: | 0020-7292 |
| Popis: | Hemolysis, elevated liver enzymes, and low Ž . platelet HELLP syndrome is a type of severe preeclampsia that threatens both mother and fetus. Several treatment strategies have been considered to be beneficial in stabilization of the disease. In previous studies, the patients receiving dexamethasone for postpartum HELLP syndrome experienced a shorter disease course, faster recovery, and less morbidity 1 3 . In this report, benefits of corticosteroids in patients with postpartum HELLP syndrome were reemphasized. Ž . The study group dexamethasone-group consisted of nine postpartum patients with HELLP syndrome who were managed between 1997 and 1999 at the Department of Obstetrics and Gynecology, Trakya University. The retrospectively assigned control group consisted of 11 postpartum patients with HELLP syndrome who were managed without dexamethasone between 1994 and |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text